Ruanyun Edai Technology Inc. Ordinary shares
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $35.0M
- Price
- $0.9375
- % Change (Daily % change from the live per-ticker quote feed.)
- -3.92%
- Volume
- 26.4K
About
Ruanyun Edai Technology Inc. is a holding company established in the Cayman Islands, which conducts its primary operations in China, developing artificial intelligence-powered solutions tailored for the K-12 educational sector.
Quick stats
Shares outstanding37.3M
Computed float—
Float / sharesUnknown
Cash runway (months)0.8
Key info
SectorTechnology
IndustrySoftware - Application
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001873454
Websitehttp://www.ruanyun.net
AI Summary
AI-generated1/25
standardbullishpartnership
BioNexus to Build AI Applications for Malaysian Healthcare Under Exclusive CogniAI Licence
BioNexus Gene Lab (BGLC) signed a definitive agreement with Ruanyun Edai Technology (RYET) for a 10-year exclusive Malaysian healthcare licence to the CogniAI document-intelligence platform.
BGLC will pay the US$3.5 million licence consideration entirely in stock (410,000 shares) plus 150,000 shares in a share exchange, with a 10% royalty to RYET on receipts collected and no cash outlay.
The first target is Malaysia's RM1 billion public healthcare digitalization programme covering 150 hospitals and 2,000+ clinics, but BGLC has not been awarded any government contract and closing remains subject to due diligence, approvals, and technology delivery by December 4, 2026.
Red flags
- closing is pending and either party may terminate if closing has not occurred by March 31, 2027
- BGLC has not been awarded any government contract; revenue depends entirely on procurement
- licence consideration paid in shares creates dilution (560,000 total shares issued)
- both parties have going-concern uncertainties disclosed in filings
- deal subject to required PRC technology-export approvals
- US$3.5 million consideration is a contractual amount, 'not a statement of fair value'